Your browser doesn't support javascript.
COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, March 1-June 30, 2020.
Acosta, Anna M; Mathis, Adria L; Budnitz, Daniel S; Geller, Andrew I; Chai, Shua J; Alden, Nisha B; Meek, James; Anderson, Evan J; Ryan, Patricia; Kim, Sue; Como-Sabetti, Kathryn; Torres, Salina; Dufort, Elizabeth; Bennett, Nancy M; Billing, Laurie M; Sutton, Melissa; Keipp Talbot, H; George, Andrea; Pham, Huong; Hall, Aron J; Fry, Alicia; Garg, Shikha; Kim, Lindsay.
  • Acosta AM; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Mathis AL; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Budnitz DS; All Native Synergies Company, Winnebago, Nebraska, USA.
  • Geller AI; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Chai SJ; US Public Health Service, Rockville, Maryland, USA.
  • Alden NB; COVID-NET Surveillance Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Meek J; US Public Health Service, Rockville, Maryland, USA.
  • Anderson EJ; US Public Health Service, Rockville, Maryland, USA.
  • Ryan P; California Emerging Infections Program, Oakland, California, USA.
  • Kim S; Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Como-Sabetti K; Colorado Department of Public Health and Environment, Denver, Colorado, USA.
  • Torres S; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA.
  • Dufort E; Emory University School of Medicine, Atlanta, Georgia, USA.
  • Bennett NM; Georgia Emerging Infections Program, Atlanta, Georgia, USA.
  • Billing LM; Veterans Affairs Medical Center, Atlanta, Georgia, USA.
  • Sutton M; Maryland Department of Health, Baltimore, Maryland, USA.
  • Keipp Talbot H; Michigan Department of Health and Human Services, Lansing, Michigan, USA.
  • George A; Minnesota Department of Health, St. Paul, Minnesota, USA.
  • Pham H; New Mexico Department of Health, Santa Fe, New Mexico, USA.
  • Hall AJ; New York State Department of Health, Albany, New York, USA.
  • Fry A; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • Garg S; Ohio Department of Health, Columbus, Ohio, USA.
  • Kim L; Oregon Health Authority, Portland, Oregon, USA.
Open Forum Infect Dis ; 7(11): ofaa528, 2020 Nov.
Article in English | MEDLINE | ID: covidwho-960576
ABSTRACT
Using a coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network, we found that 42.5% of hospitalized COVID-19 cases with available data from March 1-June 30, 2020, received ≥1 COVID-19 investigational treatment. Hydroxychloroquine, azithromycin, and remdesivir were used frequently; however, hydroxychloroquine and azithromycin use declined over time, while use of remdesivir increased.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Open Forum Infect Dis Year: 2020 Document Type: Article Affiliation country: Ofid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Open Forum Infect Dis Year: 2020 Document Type: Article Affiliation country: Ofid